Atlanta, GEORGIA4 Active Studies

Bladder Cancer Clinical Trials in Atlanta, GEORGIA

Find 4 actively recruiting bladder cancer clinical trials in Atlanta, GEORGIA. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
1,556
Enrolling

Recruiting Bladder Cancer Studies in Atlanta

RecruitingAtlanta, GEORGIANCT03547973

Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

The objective of this study is to evaluate the efficacy and safety of sacituzumab govitecan-hziy monotherapy and with novel combinations in participants with metastatic urothelial cancer (mUC)....

827 participants
Gilead Sciences
View Study Details
RecruitingAtlanta, GEORGIANCT06510374

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants with Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR NMIBC)...

454 participants
Ferring Pharmaceuticals
View Study Details
RecruitingAtlanta, GEORGIANCT06545955

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

The pivotal phase 3 trial (rAd-IFN-CS 003) evaluating the efficacy of nadofaragene firadenovec showed that 55 (53.4%) of 103 subjects with CIS ± high-grade Ta/T1 achieved a complete response (CR) at 3...

250 participants
Ferring Pharmaceuticals
View Study Details
RecruitingAtlanta, GEORGIANCT05756569

Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology

This phase II trial tests how well enfortumab vedotin (EV) and pembrolizumab works in treating patients with bladder cancer of variant histology (a group of less common types of bladder cancer) that h...

25 participants
Emory University
View Study Details

About Bladder Cancer Clinical Trials in Atlanta

Bladder cancer occurs in the tissues of the bladder and is one of the most common cancers. It has a high recurrence rate, requiring ongoing monitoring. Treatments include surgery, intravesical therapy, chemotherapy, and immunotherapy.

There are currently 4 bladder cancer clinical trials recruiting participants in Atlanta, GEORGIA. These studies are seeking a combined 1,556 participants. Research is being sponsored by Gilead Sciences, Ferring Pharmaceuticals, Emory University. Clinical trial participation is free and participants receive study-related medical care at no cost.

Bladder Cancer Clinical Trials in Atlanta — FAQ

Are there bladder cancer clinical trials in Atlanta?

Yes, there are 4 bladder cancer clinical trials currently recruiting in Atlanta, GEORGIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Atlanta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.

Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.

What bladder cancer treatments are being tested?

The 4 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for bladder cancer.

Data updated March 2, 2026 from ClinicalTrials.gov